S. Hofma

发表

Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.

P. Harst, M. Voskuil, P. van der Harst, 2021, International journal of cardiology.

Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions

P. Harst, J. Wykrzykowska, P. van der Harst, 2017, Netherlands Heart Journal.

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

M. Voskuil, M. Gimbel, T. Bergmeijer, 2020, The Lancet.

Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial.

P. Smits, S. Hofma, A. W. van ‘t Hof, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model.

P D Verdouw, W. J. van der Giessen, H. V. van Beusekom, 1998, European heart journal.

No change in endothelial-dependent vasomotion late after coronary irradiation.

P. Serruys, P. Lemos, W. J. van der Giessen, 2004, Cardiovascular radiation medicine.

Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.

J. Reiber, P. Serruys, A. Íñiguez, 2022, American heart journal.

Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals

P. Stella, A. V. Van't Hof, J. M. Berg, 2013, Netherlands Heart Journal.

Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention

S. Hofma, P. Knaapen, A. V. van Boven, 2019, Netherlands Heart Journal.

A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.

M. Beijk, J. Tijssen, R. D. de Winter, 2020, International journal of cardiology.

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

P. Serruys, M. Beijk, J. Tijssen, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).

M. Togni, P. Smits, M. Valdés, 2017, JACC. Cardiovascular interventions.

Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry

R. Hermanides, S. Hofma, J. M. Berg, 2021, BMC Cardiovascular Disorders.

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II stu

P. Serruys, L. Räber, A. Íñiguez, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial

M. Voskuil, C. von Birgelen, M. Gimbel, 2020, Journal of clinical medicine.

Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease.

P. Serruys, P. Lemos, P. D. de Feyter, 2004, The Journal of invasive cardiology.

INTERVENTIONAL CARDIOLOGY AND SURGERY One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents

M. Valgimigli, E. Regar, S. Hofma, 2005 .

New polyurethane valves in new soft artificial hearts.

S. Hofma, W. Kolff, S. Topaz, 1989, ASAIO transactions.

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study

P. Serruys, J. Tijssen, R. D. de Winter, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial.

P. Serruys, R. D. de Winter, A. Zaman, 2021, Circulation. Cardiovascular interventions.

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease

S. Saito, A. Baumbach, J. Wykrzykowska, 2021 .

Outcome of transcatheter aortic valve replacement in patients over 85 years of age versus patients aged 85 and younger

S. Hofma, A. V. van Boven, H. Amrane, 2022, Netherlands Heart Journal.

The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy

P. Serruys, J. Tijssen, R. D. de Winter, 2020, The International Journal of Cardiovascular Imaging.

Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experience.

S. Hofma, A. Kappetein, S. Head, 2014, Interactive cardiovascular and thoracic surgery.

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.

P. Serruys, R. D. de Winter, S. Garg, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial

P. Serruys, M. Beijk, J. Tijssen, 2019, The International Journal of Cardiovascular Imaging.

Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users

J. Wykrzykowska, R. V. van Geuns, E. Regar, 2015, Netherlands Heart Journal.

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI.

J. Tijssen, R. D. de Winter, J. Wykrzykowska, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial).

P. Serruys, L. Räber, A. Íñiguez, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcome of transcatheter aortic valve replacement in patients over 85 years of age versus patients aged 85 and younger

S. Hofma, A. V. van Boven, H. Amrane, 2022, Netherlands Heart Journal.

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease

S. Saito, A. Baumbach, J. Wykrzykowska, 2021, Circulation.

Drug-eluting stents in primary percutaneous coronary intervention for acute myocardial infarction.

S. Hofma, A. V. van Boven, 2006, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.

P. Serruys, P. Lemos, P. D. de Feyter, 2006, European heart journal.

Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials.

G. Stone, H. Suryapranata, G. De Luca, 2017, International journal of cardiology.

Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model

S. Hofma, L. Geven, E. V. van Roon, 2014, Netherlands Heart Journal.

Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.

P D Verdouw, P W Serruys, P. Serruys, 1996, Circulation.

Short-term effects of Nano + TM polymer-free sirolimus-eluting stents on native coronary vessels : an optical coherence tomography imaging study

P. Serruys, H. Garcia-Garcia, Shimpei Nakatani, 2015 .

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

J. Tijssen, R. D. de Winter, J. Wykrzykowska, 2017, The New England journal of medicine.

Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, The American journal of cardiology.

Vascular response after implantation of coated and non-coated coronary stents

S. Hofma, 2005 .

Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery

P. Serruys, P. Lemos, P. D. de Feyter, 2004, Coronary artery disease.

Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction.

P. Serruys, P. Lemos, P. D. de Feyter, 2004, Journal of the American College of Cardiology.

hort-and Long-Term Clinical Benefit of Sirolimus-luting Stents Compared to Conventional Bare tents for Patients With Acute Myocardial Infarction

P. Smits, S. Hofma, J. Daemen, 2016 .

Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings.

P. Serruys, Chi‐Hang Lee, P. Lemos, 2004, The American journal of cardiology.

Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.

S. Hahn, Si‐Hyuck Kang, D. Kandzari, 2013, American heart journal.

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin-E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry

Patrick W Serruys, Muzaffer Degertekin, Joost Daemen, 2004, Circulation.

Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study

Patrick W Serruys, Dick M. Goedhart, Pedro A Lemos, 2004, Circulation.

Pathobiology of coronary stents.

W. J. van der Giessen, H. V. van Beusekom, S. Hofma, 2001, Journal of interventional cardiology.

Association between angiographic culprit lesion and out-of-hospital cardiac arrest in ST-elevation myocardial infarction patients.

M. Kuiper, J. Jukema, M. Schalij, 2013, Resuscitation.

The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy

S. Saito, A. Baumbach, M. Leon, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.

Volker Klauss, Patrick W Serruys, William Wijns, 2010, The New England journal of medicine.

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-elu

M. Togni, P. Smits, J. Goy, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

M. Togni, P. Smits, S. Hofma, 2013, The Lancet.

Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.

P. Serruys, A. Íñiguez, J. Wykrzykowska, 2020, Atherosclerosis.

Objectives Background Methods Results Conclusions

P. Smits, S. Hofma, J. Brouwer, 2022 .

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.

P. Serruys, G. Stone, L. Räber, 2019, Journal of the American College of Cardiology.

Stent fracture and restenosis in the drug‐eluting stent era

Patrick W Serruys, Pedro A Lemos, P. Serruys, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Coronary Restenosis After Sirolimus‐Eluting Stent Implantation: Morphological Description and Mechanistic Analysis From a Consecutive Series of Cases

Patrick W Serruys, Muzaffer Degertekin, Joost Daemen, 2003, Circulation.

Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions.

Patrick W Serruys, Muzaffer Degertekin, Pedro A Lemos, 2004, Journal of the American College of Cardiology.

Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.

P. Serruys, L. Räber, A. Íñiguez, 2017, JACC. Cardiovascular interventions.

Recent Developments in Coated Stents.

P. Serruys, W. J. van der Giessen, H. V. van Beusekom, 2001, Current interventional cardiology reports.

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutan

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction

P. Smits, S. Hofma, J. Brouwer, 2014, Netherlands Heart Journal.

Prehospital risk stratification in patients with chest pain

S. Hofma, P. van der Meer, R. V. van Roosmalen, 2021, Emergency Medicine Journal.

Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, The American journal of cardiology.

Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.

P. Serruys, P. Lemos, P. D. de Feyter, 2004, The American journal of cardiology.

Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation

Ana Catarina Fonseca, E. G. Marcos, S. Hofma, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries.

W. J. van der Giessen, H. V. van Beusekom, V. V. van Hinsbergh, 1998, Journal of the American College of Cardiology.

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

P. Serruys, L. Räber, A. Íñiguez, 2015, European heart journal.

Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.

P. Serruys, S. Silber, J. Wykrzykowska, 2011, JACC. Cardiovascular interventions.

Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents.

P. Serruys, P. Lemos, P. D. de Feyter, 2005, The American journal of cardiology.

Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Circulation. Cardiovascular interventions.

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

P. Serruys, R. D. de Winter, B. Hamer, 2017, The Lancet.

One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents

C. V. van Mieghem, P. D. de Feyter, M. Valgimigli, 2005, Heart.

Sirolimus-Eluting Stent Implantation in ST-Elevation Acute Myocardial Infarction: A Clinical and Angiographic Study

P. Serruys, Chi‐Hang Lee, P. Lemos, 2003, Circulation.

Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III

A. Baumbach, S. Windecker, A. Lansky, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Outcomes Following Elective Percutaneous Coronary Intervention Without On-Site Surgical Backup in a Community Hospital

S. Saito, K. Tanabe, S. Hofma, 2005 .

Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter.

P. Serruys, P. Lemos, P. D. de Feyter, 2004, The American journal of cardiology.

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents

S. Hofma, J. Brouwer, A. V. van Boven, 2013, PloS one.

CHAPTER 8 Two-year results of an open-label randomized comparison of everolimus-eluting stents and sirolimus-eluting stents

S. Hofma, J. Brouwer, M. A. Velders, 2014 .

Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.

P. Smits, S. Hofma, J. Brouwer, 2012, Journal of the American College of Cardiology.

Diabetic keto-acidosis and hyperkalaemia induced pseudo-myocardial infarction

E. Regar, S. Hofma, A. Ong, 2005, Heart.

Late-Late Occlusion After Intracoronary Brachytherapy

P. Serruys, N. Mollet, S. Hofma, 2003 .

PROSPECTIVE RANDOMIZED COMPARISON BETWEEN XIENCEV AND CYPHER STENTS

S. Hofma, J. Brouwer, M. Quéré, 2010 .

Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trial.

R. Oemrawsingh, S. Hofma, J. van Kuijk, 2023, The American journal of cardiology.

Sirolimus-Eluting Stent Implantation in ST-Elevation Acute Myocardial Infarction: A Clinical and Angiographic Study

P. Serruys, Chi‐Hang Lee, P. Lemos, 2003, Circulation.

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

TCT-41 A Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin-Strut Sirolimus-Eluting Coronary Stent Supraflex: 2-Year Results of the TALENT Trial

P. Serruys, B. Merkely, A. Zaman, 2019, Journal of the American College of Cardiology.

P. Serruys, R. D. de Winter, A. Zurakowski, 2017, The Lancet.

Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial.

J. Tijssen, R. D. de Winter, J. Wykrzykowska, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial.

M. Beijk, J. Tijssen, R. D. de Winter, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry

R. Hermanides, S. Hofma, G. Amoroso, 2021, European heart journal open.